Compartmental heterogeneity of soluble phospholipases A
- PMID: 2323810
- DOI: 10.1007/BF00917456
Compartmental heterogeneity of soluble phospholipases A
Abstract
Multiple forms of soluble phospholipase A2 (PLA2) are known to coexist in venoms of individual reptilian species. While similar observations in several mammalian species suggest that this is a common phenomenon, the functional implications are not yet understood. In attempting to devise therapeutic strategies for treatment of inflammatory disorders by inhibition of PLA2, it is imperative to define the various PLA2 species in the relevant compartments. Herein, we report the presence of three PLA2 isotypes in rheumatoid arthritis serum, one pancreatic and two nonpancreatic phospholipases A2. The pancreatic and one of the nonpancreatic forms were optimally active in 7 mM calcium at pH 7.5. The other nonpancreatic form was calcium-independent and optimally active at pH 7.0. Only the calcium-dependent nonpancreatic form was observed in rheumatoid synovial fluid. Of the three serum isotypes, only the calcium-dependent nonpancreatic form correlated with markers of disease activity, such as the joint count and Landsbury index. Therefore, not all soluble or circulating phospholipases A2 are relevant to inflammatory processes. Selective inhibition of the proinflammatory form of PLA2 may prove to have some therapeutic benefit while minimizing the possible adverse effects of this form of intervention.
Similar articles
-
Biochemical characterization of soluble phospholipase A2 from rheumatoid synovial fluid.Agents Actions. 1989 Jun;27(3-4):477-80. doi: 10.1007/BF01972857. Agents Actions. 1989. PMID: 2508447
-
Characterization of extracellular phospholipase A2 in rheumatoid synovial fluid.Life Sci. 1985 Feb 11;36(6):579-87. doi: 10.1016/0024-3205(85)90640-x. Life Sci. 1985. PMID: 3918225
-
Phospholipase A2 activity in sera and synovial fluids in rheumatoid arthritis and osteoarthritis. Its possible role as a proinflammatory enzyme.J Rheumatol. 1985 Apr;12(2):211-6. J Rheumatol. 1985. PMID: 4032400
-
Secretory synovial fluid phospholipase A2 and its role in the pathogenesis of inflammation in arthritis.J Rheumatol. 1988 Nov;15(11):1601-3. J Rheumatol. 1988. PMID: 3070027 Review. No abstract available.
-
Synovial fluid phospholipase A2s and inflammation.Ann Rheum Dis. 1989 Apr;48(4):267-9. doi: 10.1136/ard.48.4.267. Ann Rheum Dis. 1989. PMID: 2653242 Free PMC article. Review.
Cited by
-
Flavonoids as phospholipase A2 inhibitors: importance of their structure for selective inhibition of group II phospholipase A2.Inflammation. 1997 Jun;21(3):347-56. doi: 10.1023/a:1027306118026. Inflammation. 1997. PMID: 9246576
-
Enzymatic activity and immunoreactivity of extracellular phospholipase A2 in inflammatory synovial fluids.Inflammation. 1992 Oct;16(5):451-7. doi: 10.1007/BF00918971. Inflammation. 1992. PMID: 1428121
-
Induction of circulating phospholipase A(2) by intravenous administration of recombinant human tumour necrosis factor.Mediators Inflamm. 1992;1(4):235-40. doi: 10.1155/S0962935192000358. Mediators Inflamm. 1992. PMID: 18475466 Free PMC article.
-
Selective inhibition of group II phospholipase A2 by quercetin.Inflammation. 1993 Oct;17(5):573-82. doi: 10.1007/BF00914195. Inflammation. 1993. PMID: 8225564
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical